Laddar...
Cardio-toxicity of checkpoint inhibitors
Immune checkpoint inhibitors (ICIs) have started revolutionizing the treatment of numerous advanced oncological diseases by restoring immune resistance against cancer cells. ICI-associated cardiac adverse effects are rare, but severe. About 50% of cardiac complications comprise myocarditis with vari...
Sparad:
| I publikationen: | J Thorac Dis |
|---|---|
| Huvudupphovsmän: | , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
AME Publishing Company
2018
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6328389/ https://ncbi.nlm.nih.gov/pubmed/30701107 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jtd.2018.12.78 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|